For manufacturers working with complex devices, selecting the right toxicity testing strategy, finding the right partner to execute it and navigating regulatory compliance can be a major hurdle. Eurofins Medical Device Services network of laboratories understands the stakes, which is why we work in close collaboration with our partner laboratories to provide access to expertly executed subacute, subchronic, and chronic toxicity studies. Together, we deliver testing solutions that meet ISO 10993 and other global regulatory standards.

Subacute toxicity studies typically span 14 to 28 days, while subchronic studies run up to 90 days, assessing systemic toxicity after repeated exposure. Chronic studies can last 12 months or longer, capturing long-term, delayed or cumulative effects. Our studies cover all relevant routes of administration, including oral, dermal, subcutaneous, intravenous, infusion, intrathecal, intramuscular, ocular, dietary, inhalation. 

Each study is tailored to your medical device and is both reliable and robust. With full clinical pathology, including clinical chemistry, haematology, coagulation, as well as necropsy, organ weights, and histopathology. We ensure the safety, compliance, and performance of your product.

^*All testing is completed by our partner labs.